Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
2.32M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
3.18M
-
Shares change
-
+211K
-
Total reported value, excl. options
-
$33.9M
-
Value change
-
+$2.36M
-
Number of buys
-
8
-
Number of sells
-
-7
-
Price
-
$10.66
Significant Holders of Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) as of Q1 2024
29 filings reported holding BLAC - Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share as of Q1 2024.
Bellevue Life Sciences Acquisition Corp. - Common Stock, par value $0.0001 per share (BLAC) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.18M shares
.
Largest 10 shareholders include COWEN AND COMPANY, LLC (370K shares), BERKLEY W R CORP (323K shares), WOLVERINE ASSET MANAGEMENT LLC (292K shares), Polar Asset Management Partners Inc. (260K shares), AQR Arbitrage LLC (250K shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (245K shares), FIR TREE CAPITAL MANAGEMENT LP (215K shares), Exos Asset Management LLC (200K shares), Walleye Capital LLC (168K shares), and Periscope Capital Inc. (150K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.